Home
Background
Scientific Approach
Pipeline
Press
Contact
Error 404 Not Found
Oops. Fail. The page cannot be found.
Please check your URL or use the search form below.
Recent Press
Radikal Therapeutics awarded funding by Health and Human Services (HHS) for development of inhaled chlorine antidote R-107
October 10, 2016
Radikal Therapeutics announces hiring of C. Edwin Garner, Ph.D. as Director of Metabolism and Pharmacokinetics
January 1, 2014
Radikal Therapeutics awarded Phase 1 Small Business Innovation grant by the National Institutes of Health for investigation of a novel therapy of Ventilatory Trauma
September 16, 2013
Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of Lung Transplantation
August 28, 2013
Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of bronchopulmonary dysplasia
August 3, 2013
Radikal Therapeutics awarded Phase 2 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of Limb Ischemia Reperfusion Injury
July 23, 2013
Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of bronchopulmonary dysplasia
July 11, 2013
Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of inflammatory bowel disease
April 29, 2013
Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant by the National Institutes of Health for investigation of a novel therapy of Diabetes Mellitus
February 19, 2013
Radikal Therapeutics announces hiring of Zsuzsanna Zsellenger, M.D., Ph.D. as Director of Investigational Pathology
February 18, 2013